Spectrum of malignant pleural and pericardial disease on FDG PET/CT

American Journal of Roentgenology

Volumn 198, Issue 3, 2012, Pages 678-685

  Makis, William ^a   Ciarallo, Anthony ^b   Hickeson, Marc ^b   Rush, Christopher ^c   Novales Diaz, Javier A ^b   Derbekyan, Vilma ^b   Laufer, Jerome ^c   Stern, Jerry ^c   Lisbona, Robert ^b  

^a Brandon Regional Health Centre   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

FDG; Malignancy; Pericardial; PET CT; Pleural

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER STAGING; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; DRUG UPTAKE; HUMAN; IMAGE ANALYSIS; MALIGNANT NEOPLASTIC DISEASE; ONCOLOGICAL PARAMETERS; PERICARDIAL DISEASE; PLEURA DISEASE; PLEURA MESOTHELIOMA; PLEURA METASTASIS; PRIORITY JOURNAL; REVIEW;

FLUORODEOXYGLUCOSE F18; HEART NEOPLASMS; HUMANS; NEOPLASM STAGING; PERICARDIUM; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84857826375     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7076     Document Type: Review

References (35)

1. Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998; 114:713-722 (Pubitemid 28433730)
2. Rusch VW, Godwin JD, Shuman WP. The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1988; 96:171-177
3. Duysinx B, Nguyen D, Louis R, et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004; 125:489-493 (Pubitemid 38223628)
4. Schaffler GJ, Wolf G, Schoellnast H, et al. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F-FDG PET. Radiology 2004; 231:858-865 (Pubitemid 38668109)
5. Kramer H, Pieterman RM, Slebos DJ, et al. PET for the evaluation of pleural thickening observed on CT. J Nucl Med 2004; 45:995-998 (Pubitemid 47611687)
6. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 2006; 21:146-153 (Pubitemid 43904262)
7. Ceresoli GL, Chiti A, Zucali PA, et al. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. J Clin Oncol 2006; 24:4587-4593 (Pubitemid 46630956)
8. Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am 2005; 43:1-21 (Pubitemid 40326556)
9. Benamore RE, O'Doherty MJ, Entwisle JJ. Use of imaging in the management of malignant pleural mesothelioma. Clin Radiol 2005; 60:1237-1247 (Pubitemid 41700403)
10. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997; 145:211-218
11. Van Marck E. Pathology of malignant mesothelioma. Lung Cancer 2004; 45:S35-S36 (Pubitemid 38917111)
12. Steele JP, Klabatsa A, Fennell DA, et al. Prognostic factors in mesothelioma. Lung Cancer 2005; 49:S49-S52 (Pubitemid 40798846)
13. Flores RM. The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 2005; 49(suppl 1):S27-S32 (Pubitemid 40798841)
14. Carretta A, Landoni C, Melloni G, et al. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases: a pilot study. Eur J Cardiothorac Surg 2000; 17:377-383 (Pubitemid 30204484)
15. Hara M, Kume M, Ohsima H, et al. F-18 FDG uptake in a malignant localized fibrous tumor of the pleura. J Thorac Imaging 2005; 20:118-119 (Pubitemid 40563437)
16. Makis W, Stern J. Hepatitis C-related primary effusion lymphoma of the pleura and peritoneum, imaged with F-18 FDG PET/CT. Clin Nucl Med 2010; 35:797-799
17. 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica 2000; 85:613-618
18. Salahudeen HM, Hoey ET, Robertson RJ, Darby MJ. CT appearances of pleural tumors. Clin Radiol 2009; 64:918-930
19. Alavi A, Gupta N, Alberini JL, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002; 32: 293-321 (Pubitemid 35332975)
20. Mavi A, Basu S, Cermik TF, et al. Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol 2009; 11:369-378
21. Kralstein J, Frishman W. Malignant pericardial diseases: diagnosis and treatment. Am Heart J 1987; 113:785-790 (Pubitemid 17036730)
22. Ost P, Rottey S, Smeets P, Boterberg T, Stragier B, Goethals I. F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report. J Thorac Imaging 2008; 23:35-38
23. Bhargava P, Glass E, Brown J, Eapen E, Ames E. FDG PET in primary effusion lymphoma (PEL) of the pericardium. Clin Nucl Med 2006; 31:18-19 (Pubitemid 43011929)
24. Chiles C, Woodard PK, Gutierrez FR, Link KM. Metastatic involvement of the heart and pericardium: CT and MR imaging. RadioGraphics 2001; 21:439-449 (Pubitemid 33707769)
25. Wadler S, Chahinian P, Slater W, Goldman M, Mendelson D, Holland JF. Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma. Cancer 1986; 58:2744-2750 (Pubitemid 17232938)
26. Abraham KP, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol 1990; 3:195-198
27. Klatt EC, Heitz DR. Cardiac metastases. Cancer 1990; 65:1456-1459 (Pubitemid 20097178)
28. Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987; 257:1088-1092 (Pubitemid 17031503)
29. Prakash P, Kalra MK, Stone JR, Shepard JA, Digumarthy SR. Imaging findings of pericardial metastasis on chest computed tomography. J Comput Assist Tomogr 2010; 34:554-558
30. Douroukas A, Arena V, Pelosi E. Detection of metastatic involvement of the pericardium on F-18 FDG-PET/CT imaging. Clin Nucl Med 2009; 34:40-41
31. 18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy. J Clin Oncol 2006; 24:3026-3031
32. Weijs LE, Arsos G, Baarslag HJ, Wittebol S, de Klerk JM. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging. Eur Heart J 2007; 28:2698 (Pubitemid 350135525)
33. Buchmann I, Wandt H, Wahl A, Reske SN. FDG PET for imaging pericardial manifestations of Hodgkin Lymphoma. Clin Nucl Med 2003; 28: 760-761 (Pubitemid 38295203)
34. Nunes H, Freynet O, Naggara N, et al. Cardiac sarcoidosis. Semin Respir Crit Care Med 2010; 31:428-441
35. Nakao K, Noguchi T, Kim J, et al. Transient constrictive pericarditis diagnosed by cardiac magnetic resonance, 67Ga scintigraphy, and positron emission tomography. Int J Cardiol 2009; 137: e70-e72